Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
AFD Pharma is an India-based nutraceutical and pharmaceutical business operating as a division of Anglo French Drugs and Industries Limited. The company markets consumer health and wellness products focused on immunity, fertility, menopausal health, sleep support, liver health, and general well-being, and it also lists selected prescription-style pharmaceutical products on its portfolio pages. Its marketed brands include Fastnap, Lyber+, Lyber M, Neugracia, AFD Shield, Limezo DZ, Livocumin, ASAP Plus, AFDOZ-O, AFDIMYCIN, and Pantophyll. AFD Pharma appears to be a commercial-stage healthcare company centered on branded supplements and related health products in India rather than a clinical-stage biotech developing novel therapeutics. The business emphasizes science-backed wellness offerings for aging, reproductive health, and preventive care.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on AFD Pharma.